# High and Low Dose Carbidopa Treatment of Parkinson's Disease

> **NCT01399905** · PHASE2 · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 14 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** carbidopa

## Key facts

- **NCT ID:** NCT01399905
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2011-04
- **Final completion:** 2011-05
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2020-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01399905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01399905, "High and Low Dose Carbidopa Treatment of Parkinson's Disease". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT01399905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*